Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STaMINA trial in Multiple Myeloma
NCT01109004Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- May 2010
- Primary completion
- Jan 2017
- Modality
- Modified Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide, bortezomib, dexamethasone in multiple myeloma (MM), sponsored by National Heart, Lung, and Blood Institute. Started May 2010; status: completed.
02
Drugs
lenalidomidebortezomibdexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01109004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109004.